期刊文献+

细菌硝基还原酶的结构与催化机制 被引量:4

Research progress of the structure and mechanism of bacterial nitroreductases
原文传递
导出
摘要 细菌硝基还原酶(nitroreductase,NTR)属于依赖黄素单核苷酸(flavin mononucleotide,FMN)的硝基还原酶超家族,通常以二聚体形式存在。它们可利用还原型烟酰胺腺嘌呤二核苷酸(磷酸)(reduced nicotinamide adenine dinucleotide(phosphate),NAD(P)H)作为电子供体,催化多种外源硝基芳香族、醌类和黄素类化合物的还原反应,在药物的激活和解毒机制中发挥重要的作用。以研究得较为透彻的大肠杆菌NTR为代表,总结了近几年细菌NTR在结构特征、构象变化及催化特性等方面的最新研究进展。最后,对细菌NTR的研究方向进行了展望。 Bacterial nitroreductases (NTRs) belong to FMN-dependent nitroreductase-like superfamily, and are mostly dimeric. They are NAD(P)H-dependent cytosolic enzymes with broad substrate spectrum including quinines, flavins and nitroaromatic compounds, and play important roles in drug activation and detoxication. Taking the well-characterized E.coli NTR NfsB and other bacteria NTR as examples, we summarized the recent research progress on the structural, conformational changes and catalytic properties of NTR. We also discussed the research perspectives in brief.
出处 《生命的化学》 CAS CSCD 2013年第1期84-90,共7页 Chemistry of Life
基金 国家自然科学基金项目(31070715) 国家重点基础发展计划("973"计划)(2010CB126102) 辽宁省科学技术计划项目(2012225113)
关键词 硝基还原酶 药物激活 序列分析 结构特征 催化特性 nitroreductase drug activation sequence analysis structural feature catalytic property
  • 相关文献

参考文献32

  • 1Villanueva JR. The purification of a nitro-reductase from Nocardia V. J Biol Chem, 1964, 239:773-776.
  • 2Whiteway J, Koziarz P, Veall J, et al. Oxygen-Insensitive nitroreductases: analysis of the roles of nfsA and nfsB in development of resistance to 5-nitrofuranderivatives in Escherichia coli. J Biochem, 1998, 180:5529-5539.
  • 3Nillius D, Mtiller J, Mtiller N. Nitroreductase (G1NR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs. J Antimicrob Chemother, 2011, 66:1029-1035.
  • 4Anlezark GM, Melton RG, Sherwood RF, et al. The bioactivation of 5-(aziridin-l-yl)-2,4- dinitrobenzamide(CB 1954)--I: purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT). Biochem Pharmacol, 1992, 44:2289-2295.
  • 5Patel P, Young JG, Mautner V, et al. A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB 1954. Mo! Ther, 2009, 17:1292-1299.
  • 6Prosser GA, Copp JN, Syddall SP, et al. Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Biochem Pharmacol, 2010, 79:678-687.
  • 7AbuKhader MM, Heap J, De Matteis CI, et al. Crystallization and preliminary X-ray characterization of the Bacillus amyloliquefaciens YwrO enzyme. Acta Crystallogr Sect F Struct Biol Cryst Commun, 2007, 63: 746-750.
  • 8Linwu SW, Wang AH, Peng FC. Flavin-containing reductase: new perspective on the detoxification of nitrobenzodiazepine. Expert Opin Drug Metab Toxicol, 2010, 6:967-981.
  • 9Manlna G, Bellinzoni M, Pasca MR, et al. Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance. Mol Microbiol, 2010, 77: 1172-1185.
  • 10Jaberipour M, Vass SO, Guise CP, et al. Testing double mutants of the enzyme nitroreductase for enhanced cell sensitisation to prodrugs: effects of combining beneficial single mutations. Biochem Pharmacol, 2010, 79: 102- 111.

同被引文献59

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部